Application Nr Approved Date Route Status External Links
NDA210874 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Qternmet Xr (Dapagliflozin, Saxagliptin, And Metformin Hydrochloride) Extended-Release Tablets Is Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. Limitations Of Use Qternmet Xr Is Not Indicated For The Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis. Qternmet Xr Initiation Is Intended Only For Patients Currently Taking Metformin. Qternmet Xr Is A Sodium-Glucose Cotransporter 2 (Sglt2) Inhibitor, A Dipeptidyl Peptidase-4 (Dpp-4) Inhibitor And A Biguanide Combination Product Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. (1) Limitations Of Use • Is Not Indicated For The Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis. (1) • Qternmet Xr Initiation Is Intended Only For Patients Currently Taking Metformin. (1)

All Formulated Excipients (0 Total)

None

Comments